Regional Analysis
Thrombin Inhibitor Market Regional Insights
- North America is expected to hold 35.0% market share during the forecast period due to the presence of a large patient population suffering from thrombosis-related disorders, the high healthcare expenditure, and the availability of advanced healthcare infrastructure in the region.
- Europe is expected to hold 24.4% market share due to the increasing prevalence of thrombosis-related disorders and the rising adoption of anticoagulant therapies for the same in the region.
- The Asia Pacific region is expected to witness 8.2% growth rate during the forecast period due to the increasing incidence of thrombosis-related disorders, the rising healthcare expenditure, and the growing focus on the development of advanced anticoagulant therapies in the region.
Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC, Israel, Rest of Middle East
- Africa: South Africa, North Africa, Central Africa
|
U.S.: 
U.K. : 
India : 
